Search Details

Word: kwak (lookup in dictionary) (lookup stats)
Dates: during 2000-2009
Sort By: most recent first (reverse)


Usage:

...about the excessive consumption of the fish. I had to fight the urge to run to a nearby restaurant every time I looked at the cover. I think it is a little paradoxical to use such a luscious photo when the article is warning consumers about eating tuna. Jiwon Kwak, Seoul...

Author: /time Magazine | Title: Inbox | 11/30/2009 | See Source »

...Gazans aren't digging for fun: it is a matter directly related to their lives. What does Israel earn from trying to prevent a hungry person from eating? I really hope that these meaningless hostilities will fade. Jiwon Kwak, Seoul...

Author: /time Magazine | Title: Inbox | 11/23/2009 | See Source »

...always thought was completely ingrained in humanity looks like it is actually changing. It seems the mood surrounding most consumers has shifted to a more ethical one. I was so happy to read this article and I'm starting to see hope for a greener future. Jiwon Kwak, Seoul...

Author: /time Magazine | Title: Inbox | 10/12/2009 | See Source »

...vaccine for follicular lymphoma is not new. Stanford University's Ron Levy pioneered the effort more than 25 years ago, demonstrating that anti-idiotype antibodies could be produced in a laboratory and used to create a vaccine for humans that would trigger an immune response. In 1999 Kwak, then working at the National Institutes of Health (nih), modified the vaccine in a way that makes it easier for the immune system to recognize. His results were striking: the vaccine eliminated the residual tumor cells left after chemotherapy in 15 of his 20 patients. Now Bendandi, who worked with Kwak...

Author: /time Magazine | Title: The Disease is the Remedy | 4/11/2007 | See Source »

...England Journal of Medicine, says, "Using patients as their own control is a bit shaky, especially for follicular lymphoma." A Phase III randomized trial, more difficult but still possible to conduct even with customized vaccines remains, he says, "the gold standard for proof of efficacy." Dr. Kwak, who is conducting his own Phase III trial of a vaccine for the American pharmaceutical company Biovest, believes his former trainee's results support the case for a therapeutic lymphoma vaccine, but is skeptical about his methods. "Dr. Bendandi's study is important because it confirms previously reported results. But taken in isolation...

Author: /time Magazine | Title: The Disease is the Remedy | 4/11/2007 | See Source »

| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | Next